Skip to main content
. 2022 Aug 19;114(11):1468–1475. doi: 10.1093/jnci/djac153

Table 2.

Demographic of patients with pancreatic cancer who undergone a pancreatectomy

Variables Caregivers not working for pay (n = 133) Caregivers working for pay (n = 107) P a
Sex, No. (%)
 Female 48 (41.4) 45 (44.6) .64
 Male 85 (58.6) 62 (45.4)
Age at time of surgery, median (IQR), y 70.8 (63.8-75.8) 63.8 (58.8-73.0) .006
Race, No. (%) .88
  African American, African descent, or Black 9 (7.8) 6 (5.9)
  Otherb 23 (17.3) 13 (12.1)
  White 101 (87.1) 88 (87.1)
BMI, median (IQR,) kg/m2 24.9 (23.8-27.5) 25.1 (21.3-28.5) .47
ASA class 3-4, No. (%) 78 (67.3) 73 (72.3) .68
Pathology, No. (%) .11
  Pancreatic adenocarcinoma 93 (69.9) 73 (68.2)
  Pancreatic IPMN 6 (4.5) 6 (5.6)
  Ampullary adenocarcinoma 3 (2.3) 7 (6.5)
  Distal cholangiocarcinoma 1 (0.8) 5 (4.7)
  Duodenal adenocarcinoma 1 (0.8) 2 (1.9)
  Other 29 (21.8) 14 (13.1)
Hospital length of stay, median (IQR) 6.0 (5.0-9.5) 6.0 (5.0-8.0) .93
Hospital discharge to home, No. (%) 114 (98.3) 95 (94.1) .10
30-day readmission, No. (%) 18 (15.5) 25 (24.8) .09
Unplanned return to OR, No. (%) 5 (4.4) 1 (1.0) .13
Pre-op chemotherapy, No. (%) 52 (46.4) 26 (25.7) .002
Pre-op radiation therapy, No. (%) 37 (33.0) 23 (22.8) .09
Operation, No. (%) .98
  Pancreatoduodenectomy 94 (81.0) 82 (81.2)
  Distal pancreatectomy 22 (19.0) 19 (18.8)
Postoperative intraabdominal abscess, No. (%) 16 (12.0) 25 (23.4) .02
Postoperative delayed gastric emptying, No. (%) 9 (8.0) 7 (7.0) .05
a

Student t test and χ2 tests were used to calculate the P values for continuous and categorical variables respectively, and all tests were performed as 2-sided tests. ASA = American Society of Anesthesiologists; BMI = body mass index; IPMN = intraductal papillary mucinous neoplasm; IQR = interquartile range; OR, operating room; POD = postoperative day.

b

Includes patients who do not identify their race as White, African American, African descent, or Black.